⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
WALD News
Waldencast plc Class A Ordinary Share
Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint
globenewswire.com
WALD
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
globenewswire.com
WALD
Waldencast Announces Sale of Obagi Medical to Bridgepoint
globenewswire.com
WALD
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
globenewswire.com
WALD
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
globenewswire.com
WALD
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
globenewswire.com
WALD
Waldencast announces conclusion of SEC investigation
globenewswire.com
WALD
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
globenewswire.com
WALD
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
globenewswire.com
WALD
Waldencast Reports Q4 2025 and FY 2025 Financial Results
globenewswire.com
WALD